Clinical Trial Update: Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

View source ↗

Summary

AstraZeneca-sponsored BRA-BLADDER study evaluating bladder cancer in Brazil has completed, examining urothelial carcinoma across non-muscle invasive and muscle-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer
• Non-muscle Invasive Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: AstraZeneca | Conditions: Urothelial Carcinoma, Non Muscle Invasive Bladder Cancer | Status: COMPLETED